CDT Equity Inc. - Common Stock (CDT)
0.9448
-0.5352 (-36.16%)
NASDAQ· Last Trade: Sep 2nd, 3:18 PM EDT
Detailed Quote
| Previous Close | 1.480 |
|---|---|
| Open | 1.150 |
| Bid | 0.9305 |
| Ask | 0.9448 |
| Day's Range | 0.9000 - 1.200 |
| 52 Week Range | 1.400 - 2,719.40 |
| Volume | 1,166,411 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 232,133 |
Chart
About CDT Equity Inc. - Common Stock (CDT)
Conduit Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs, particularly in the fields of oncology and autoimmune diseases. The company leverages its expertise in drug formulation and delivery to create targeted treatment options that aim to improve patient outcomes and quality of life. By emphasizing research and development, Conduit seeks to advance its pipeline of product candidates through various stages of clinical trials, with the ultimate goal of bringing new therapies to market that address critical health challenges faced by patients. Read More
News & Press Releases
Here are the top movers in Wednesday's session.chartmill.com
Via Chartmill · September 2, 2026
Which stocks are gapping on Wednesday?chartmill.com
Via Chartmill · September 2, 2026
Discover the top movers in Wednesday's pre-market session.chartmill.com
Via Chartmill · September 2, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that, following the recent issuance of shares and the exercise of pre-funded warrants, the Company had 13,693,866 shares of Common Stock issued and outstanding as of August 31, 2026. Based on the closing price of CDT’s Common Stock on August 31, 2026, the Company had a market capitalisation of approximately $23.0 million.
By CDT Equity Inc. · Via GlobeNewswire · September 2, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 01, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced the appointment of James Bligh, co-founder of Conduit Pharmaceuticals Limited (now CDT), as Chief Executive Officer. Mr. Bligh brings extensive public-markets, corporate finance and transaction experience to the role and will lead the Company as it enters its next phase of growth and value creation. Dr. Andrew Regan has been appointed as CEO of Sarborg Limited.
By CDT Equity Inc. · Via GlobeNewswire · September 1, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that new solid forms and alternative crystal structures of its existing drug compounds, show enhanced physical property advantages, including improved stability, solubility, manufacturability, over existing forms of these compounds. These solid forms are patent-protected under the Company’s Substance of Matter IP and could support new formulations tailored to specific patient needs, prospectively increasing the commercial life of the underlying assets.
By CDT Equity Inc. · Via GlobeNewswire · August 28, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has entered into a SAFE note with Pep'd Inc. (“Pep'd”), a US-based peptide company, expanding CDT's exposure to the growing US peptide market (the “Transaction”). Upon Pep’d closing an Equity Financing, this SAFE will automatically convert into a number of shares of Safe Preferred Stock, depending on the Pep’d Capitalization at that time and a Valuation Cap of $10,000,000.
By CDT Equity Inc. · Via GlobeNewswire · August 25, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that it has entered into a strategic transaction to increase its equity stake in Sarborg Limited (“Sarborg”), an agentic AI signature intelligence business operating across multiple industrial sectors, to 22.7% through the issuance of pre-funded warrants to purchase up to 12,131,770 shares of the Company’s common stock, subject to shareholder approval at the Company’s annual meeting of stockholders on August 28, 2026 (the “Transaction”).
By CDT Equity Inc. · Via GlobeNewswire · August 3, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, July 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the filing of a new patent application covering a large set of field-deployable, two-component combination interventions for sugarcane cultivation, generated through Sarborg's quantum-enabled PRISM platform.
By CDT Equity Inc. · Via GlobeNewswire · July 20, 2026
Get insights into the top gainers and losers of Thursday's pre-market session.chartmill.com
Via Chartmill · July 16, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, July 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-10 reverse stock split of the Company’s common stock, to ensure continued compliance with the Nasdaq bid-price rule. The Company’s stockholders approved future reverse stock splits, their timing, and granted the board of directors authority to determine future exact split ratios.
By CDT Equity Inc. · Via GlobeNewswire · July 16, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the expansion of its Signature Intelligence platform into quantum-assisted coformer selection through SarborgQ, the Company's dedicated quantum computing division.
By CDT Equity Inc. · Via GlobeNewswire · June 26, 2026
Here are the top movers in Thursday's session.chartmill.com
Via Chartmill · June 25, 2026
Keep an eye on the top gainers and losers in Thursday's session.chartmill.com
Via Chartmill · June 25, 2026
These stocks are gapping in today's sessionchartmill.com
Via Chartmill · June 25, 2026
Which stocks are moving on Monday?chartmill.com
Via Chartmill · June 22, 2026
Top movers in Thursday's sessionchartmill.com
Via Chartmill · June 18, 2026
These stocks are making the most noise in today's session.chartmill.com
Via Chartmill · June 18, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · June 18, 2026
Thursday's session: gap up and gap down stockschartmill.com
Via Chartmill · June 18, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding its recent fundraise from a New York-based private investment fund.
By CDT Equity Inc. · Via GlobeNewswire · June 18, 2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has re-structured its debt, agreeing to pay off all outstanding amounts due under its Loan Notes with Alliance Global Partners (“A.G.P.”) and Ascent Partners, and entering into a new Loan Agreement with JJ Astor for up to $1,460,000.
By CDT Equity Inc. · Via GlobeNewswire · June 16, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · May 29, 2026
Keep an eye on the top gainers and losers in Friday's session.chartmill.com
Via Chartmill · May 29, 2026
Friday's session: gap up and gap down stockschartmill.com
Via Chartmill · May 29, 2026